Birth Control Pill Reminder vs TAK

Birth Control Pill Reminder is an easy-to-use and reliable app that helps you take your pills every day at the time you choose. It has a Pre-Alarm and Auto-Snooze feature to ensure you don't forget to take your pills. It tracks the remaining quantity and shows a refill alert when you're running low. The number of pills per packet is customizable, making it compatible with all types of birth control pills. It also reminds you to use your ring or patch. The app doesn't need to be running to receive notifications. MAIN FEATURES • 3 supported birth control methods (Pills, Ring, and Patch) • Compatible with all birth control pill types (21/7, 24/4, 28, 35, 84/7, ...) • Ring days are customizable (21/7, 25/3, 28/0, ...) • Patch weeks are customizable (3 weeks, 9 weeks, 12 weeks, ...) • Reminders to take your placebo (non-active) pills • Configurable reminder message allows discretion when getting notified • Pre-Alarms: Receive notifications before the actual time • Auto-Snooze: Allows the alarm to repeat up to 5 times at regular intervals (e.g. 1 min, 10 mins, 30 mins) until you take action • Option to Snooze or mark it as Done directly from the lock screen or notification banners • Take notes every day for future reference • 2 themes to choose from: pink and blue • 24 built-in alarm sounds • Refill alerts when running low • Backup and restore all data on the same device or multiple devices • Password Protection GENERAL • VoiceOver accessibility support • Dark Mode • Notifications are local. No internet connection required • App doesn't need to be open to receive notifications • Universal App, full native support for iPhone and iPad FREE VERSION • Pre-Alarms, Auto-Snooze, Snooze, and Password Protection are available in the full version • Full version is available as an In-App Purchase • One-Time payment. No monthly or annual fees

An app for the TAK-660-403 Protocol. Evaluation of long-term safety of ADYNOVI / ADYNOVATE(Antihaemophilic Factor [Recombinant] PEGylated, rurioctocog alfa pegol) in patients with haemophilia A – An ADYNOVI / ADYNOVATE Post-Authorisation Safety Study (PASS)